Nonsteroidal anti-inflammatory drugs comprise an important class of me
dications that reduce the signs and symptoms of osteoarthritis and rhe
umatoid arthritis. They bring relief to millions of people but do not
eliminate underlying disease. Disease-modifying antirheumatic drugs al
so bring relief, but these drugs are often ineffective and not well to
lerated. Failure to provide long-term benefits combined with the high
toxicity of most of the disease-modifying agents has prompted a search
for more effective treatments. New methods using modem technologies h
ave generated much enthusiasm and hold promise for the future In the m
eantime, administration of nonsteroidal anti-inflammatory drugs and ju
dicious use of disease-modifying agents remain the cornerstone of ther
apy for arthritis.